These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22815080)

  • 41. Racial differences in the effect of APOE-ε4 genotypes on trail making test B in Alzheimer's disease: A longitudinal study.
    Xu C; Acevedo P; Lu Y; Su BB; Ozuna K; Padilla V; Karithara A; Mao C; Navia RO; Piamjariyakul U; Wang K;
    Int J Geriatr Psychiatry; 2023 Dec; 38(12):e6037. PubMed ID: 38100638
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
    Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
    J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
    McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
    Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ApoE ε4 and IL-6-174G/C Polymorphism may Lead to Early Onset of Alzheimer's Disease with Atypical Presentation.
    Chakraborty S; Joardar A; Roy S; Gangopadhyay G; Biswas A
    Neurol India; 2021; 69(5):1228-1233. PubMed ID: 34747789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA; Oulhaj A; de Jager CA; Williams JH
    Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 48. APOE ε4 is associated with earlier symptom onset in LOAD but later symptom onset in EOAD.
    Polsinelli AJ; Lane KA; Manchella MK; Logan PE; Gao S; Apostolova LG
    Alzheimers Dement; 2023 May; 19(5):2212-2217. PubMed ID: 36722399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progression from amnesic mild cognitive impairment to Alzheimer's disease: ESR1 and ESR2 polymorphisms and APOE gene.
    Elcoroaristizabal Martín X; Fernández Martínez M; Galdos Alcelay L; Molano Salazar A; Bereincua Gandarias R; Inglés Borda S; Gómez Busto F; Uterga Valiente JM; Indakoetxea Juanbeltz B; Gómez Beldarraín MA; de Pancorbo MM
    Dement Geriatr Cogn Disord; 2011; 32(5):332-41. PubMed ID: 22311091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apolipoprotein E ε4 allele impairs cortical activity in healthy aging and Alzheimer's disease.
    Pedroso RV; Fraga FJ; Nascimento CMC; Pott-Junior H; Cominetti MR
    Behav Brain Res; 2022 Feb; 420():113700. PubMed ID: 34871705
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep.
    Lim AS; Yu L; Kowgier M; Schneider JA; Buchman AS; Bennett DA
    JAMA Neurol; 2013 Dec; 70(12):1544-51. PubMed ID: 24145819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cognitive phenotypes in Alzheimer's disease and genetic risk.
    Snowden JS; Stopford CL; Julien CL; Thompson JC; Davidson Y; Gibbons L; Pritchard A; Lendon CL; Richardson AM; Varma A; Neary D; Mann D
    Cortex; 2007 Oct; 43(7):835-45. PubMed ID: 17941342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Apolipoprotein E ε4 allele interacts with sex and cognitive status to influence all-cause and cause-specific mortality in U.S. older adults.
    Beydoun MA; Beydoun HA; Kaufman JS; An Y; Resnick SM; O'Brien R; Ferrucci L; Zonderman AB
    J Am Geriatr Soc; 2013 Apr; 61(4):525-34. PubMed ID: 23581910
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.
    Martinez M; Campion D; Brice A; Hannequin D; Dubois B; Didierjean O; Michon A; Thomas-Anterion C; Puel M; Frebourg T; Agid Y; Clerget-Darpoux F
    Arch Neurol; 1998 Jun; 55(6):810-6. PubMed ID: 9626772
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.
    Drzezga A; Grimmer T; Henriksen G; Mühlau M; Perneczky R; Miederer I; Praus C; Sorg C; Wohlschläger A; Riemenschneider M; Wester HJ; Foerstl H; Schwaiger M; Kurz A
    Neurology; 2009 Apr; 72(17):1487-94. PubMed ID: 19339712
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 57. APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk.
    Borroni B; Grassi M; Costanzi C; Archetti S; Caimi L; Padovani A
    Am J Geriatr Psychiatry; 2006 Dec; 14(12):1022-31. PubMed ID: 16956959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.
    Lind J; Larsson A; Persson J; Ingvar M; Nilsson LG; Bäckman L; Adolfsson R; Cruts M; Sleegers K; Van Broeckhoven C; Nyberg L
    Neurosci Lett; 2006 Mar; 396(1):23-7. PubMed ID: 16406347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects.
    Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP
    J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inheritance of the ApoE epsilon4 allele increases the rate of brain atrophy in dementia patients.
    Wahlund LO; Julin P; Lannfelt L; Lindqvist J; Svensson L
    Dement Geriatr Cogn Disord; 1999; 10(4):262-8. PubMed ID: 10364643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.